Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mendes

Showing results (311-320 of 473) with videos related to

Pageof 48
Sort By:
Microbial Drug Resistance (Larchmont, N.Y.)|August 1, 2015
Genotypic Characterization of Methicillin-Resistant Staphylococcus aureus Recovered at Baseline from Phase 3 Pneumonia Clinical Trials for CeftobiproleRodrigo E Mendes, Lalitagauri M Deshpande, Andrew J Costello, et al.
Traffic Injury Prevention|November 28, 2013
A method for linking motor vehicle victim and collision data collected by multiple county agenciesLinda Papa, Matthew E Mendes, Tom Benton, et al.
Diagnostic Microbiology and Infectious Disease|March 26, 2017
Antimicrobial activity of tigecycline and cefoperazone/sulbactam tested against 18,386 Gram-negative organisms from Europe and the Asia-Pacific region (2013-2014)M A Pfaller, R K Flamm, L R Duncan, et al.
Diagnostic Microbiology and Infectious Disease|June 19, 2012
LEADER surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers)Robert K Flamm, David J Farrell, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 2015
Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancinRonald N Jones, David J Farrell, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease|May 22, 2022
Ceftobiprole activity against Gram-positive and Gram-negative pathogens causing bone and joint infections in the United States from 2016 to 2020Leonard R Duncan, Kamal A Hamed, Jennifer I Smart, et al.
Diagnostic Microbiology and Infectious Disease|March 14, 2016
Antimicrobial activity of ceftaroline and comparator agents when tested against numerous species of coagulase-negative Staphylococcus causing infection in US hospitalsHelio S Sader, David J Farrell, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease|September 10, 2016
Telavancin activity tested against a collection of Staphylococcus aureus isolates causing pneumonia in hospitalized patients in the United States (2013-2014)Leonard R Duncan, Jennifer I Smart, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease|April 10, 2022
Aztreonam in combination with imipenem-relebactam against clinical and isogenic strains of serine and metallo-β-lactamase-producing enterobacteralesMark Biagi, Michelle Lee, Tiffany Wu, et al.
Antimicrobial Agents and Chemotherapy|December 12, 2007
Prevalence of and molecular basis for tuberculosis drug resistance in the Republic of Georgia: validation of a QIAplex system for detection of drug resistance-related mutationsMedea Gegia, Nino Mdivani, Rodrigo E Mendes, et al.
Pageof 48

Showing results (311-320 of 473) with videos related to

Sort By:
Pageof 48
Microbial Drug Resistance (Larchmont, N.Y.)|August 1, 2015
Genotypic Characterization of Methicillin-Resistant Staphylococcus aureus Recovered at Baseline from Phase 3 Pneumonia Clinical Trials for CeftobiproleRodrigo E Mendes, Lalitagauri M Deshpande, Andrew J Costello, et al.
Traffic Injury Prevention|November 28, 2013
A method for linking motor vehicle victim and collision data collected by multiple county agenciesLinda Papa, Matthew E Mendes, Tom Benton, et al.
Diagnostic Microbiology and Infectious Disease|March 26, 2017
Antimicrobial activity of tigecycline and cefoperazone/sulbactam tested against 18,386 Gram-negative organisms from Europe and the Asia-Pacific region (2013-2014)M A Pfaller, R K Flamm, L R Duncan, et al.
Diagnostic Microbiology and Infectious Disease|June 19, 2012
LEADER surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers)Robert K Flamm, David J Farrell, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 2015
Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancinRonald N Jones, David J Farrell, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease|May 22, 2022
Ceftobiprole activity against Gram-positive and Gram-negative pathogens causing bone and joint infections in the United States from 2016 to 2020Leonard R Duncan, Kamal A Hamed, Jennifer I Smart, et al.
Diagnostic Microbiology and Infectious Disease|March 14, 2016
Antimicrobial activity of ceftaroline and comparator agents when tested against numerous species of coagulase-negative Staphylococcus causing infection in US hospitalsHelio S Sader, David J Farrell, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease|September 10, 2016
Telavancin activity tested against a collection of Staphylococcus aureus isolates causing pneumonia in hospitalized patients in the United States (2013-2014)Leonard R Duncan, Jennifer I Smart, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease|April 10, 2022
Aztreonam in combination with imipenem-relebactam against clinical and isogenic strains of serine and metallo-β-lactamase-producing enterobacteralesMark Biagi, Michelle Lee, Tiffany Wu, et al.
Antimicrobial Agents and Chemotherapy|December 12, 2007
Prevalence of and molecular basis for tuberculosis drug resistance in the Republic of Georgia: validation of a QIAplex system for detection of drug resistance-related mutationsMedea Gegia, Nino Mdivani, Rodrigo E Mendes, et al.
Pageof 48